exaussie, I totally agree with Maia - but, in case you would have a chance to rather go with Pembrolizumab, it seems to be more effective in the sense of over all response rates since it acts on PD-L1 and PD-L2, furthermore it has been even shown that patients respond independently of their PD-L1 ex...